This fully updated book explores all-new and revised protocols involving the use of in silico models, particularly with regard to pharmaceuticals. Divided into five sections, the volume covers the modeling of pharmaceuticals in the body, toxicity data for modeling purposes, in silico models for multiple endpoints, a number of platforms for evaluating pharmaceuticals, as well as an exploration of challenges, both scientific and sociological. Written for the highly successful series, chapters include the kind of detail and implementation advice necessary for successful results. Authoritative and comprehensive, aims to guide the reader through the correct procedures needed to harness in silico models, a field which now touches a wide variety of research specialties.weiterlesen